New spinout to develop gene therapies targeting rare lung diseases
14.09.2023 - AlveoGene will work on gene therapies for several rare lung conditions, beginning with alpha-1 antitrypsin deficiency.
Source: myscience.uk
📰 Called Alveogene News
Called Alveogene News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Called Alveogene. Real-time updates on events, politics, business and more.